{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibjcyjoajv2zovmybe564kbc7wd3lvv3txd7oqw7usxr7n3hs7iem",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mlm7hddpne52"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihsnbsxz5kcvqdmb5pvs43vfu2xcyfotvntvo5ry6vkhjcp5g3pga"
    },
    "mimeType": "image/jpeg",
    "size": 60551
  },
  "path": "/2026/05/11/medicare-alzheimers-drugs-leqembi-kisunla-surprise-billing-lobbying/?utm_campaign=rss",
  "publishedAt": "2026-05-11T18:03:14.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Health Care Inc.",
    "Health Care Inc. Newsletter",
    "CMS",
    "drug development",
    "government agencies",
    "insurance",
    "legal",
    "Medicare",
    "Pharmaceuticals",
    "Policy",
    "STAT+"
  ],
  "textContent": "Far fewer seniors than expected are taking costly Alzheimer's drugs.",
  "title": "STAT+: Medicare’s miss on Alzheimer’s drug spending",
  "updatedAt": "2026-05-11T18:03:19.000Z"
}